Return to Research Articles

 

Doubt Cast Over the Efficacy of Aspirin - July 6, 2000

 

                       A question mark over aspirin's perceived ability to stop people

                       developing heart disease arises from a new study, involving more

                       than 5,000 men from around the UK. Aspirin has a widespread

                       reputation as a miracle life-saver but new research suggests it

                   may do more harm than good to men most at risk from

         heart disease. Thousands of middle aged men in Britain, and many

                       more in the US, take aspirin routinely as a preventative medicine

                       to lower their risk of succumbing to the western world's biggest

                       killer.

 

                       But the study suggests a daily low dose of aspirin is unlikely to

                       help men with high blood pressure - the group most vulnerable to

                       heart disease and strokes.

 

                       Indeed, it found that men with blood pressures of more than

                       145mm of mercury derived little or no heart-protective benefit.

                       And, because aspirin thins the blood, the study also suggested it

                       could increase the likelihood of serious bleeding in this group. A

                       case-control study in five UK centres found the risk of peptic ulcer

                    bleeding more than doubled among regular users.